allicin has been researched along with Alzheimer Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Catani, M; Cavazzini, A; Gessi, S; Merighi, S; Nigro, M; Tedeschi, P; Travagli, A | 1 |
| Li, Z; Liu, L; Liu, Y; Wang, P; Xue, Y; Zhang, H | 1 |
| Chen, ZY; Li, CY; Li, XH; Lu, JM; Xiang, ZG; Zhong, F | 1 |
1 review(s) available for allicin and Alzheimer Disease
| Article | Year |
|---|---|
Therapeutic Potential of Allicin and Aged Garlic Extract in Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Antioxidants; Biological Products; Disulfides; Garlic; Humans; Plant Extracts; Sulfinic Acids | 2022 |
2 other study(ies) available for allicin and Alzheimer Disease
| Article | Year |
|---|---|
Allicin ameliorates cognitive impairment in APP/PS1 mice via Suppressing oxidative stress by Blocking JNK Signaling Pathways.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cognitive Dysfunction; Disease Models, Animal; Disulfides; Humans; Mice; Mice, Transgenic; Neurons; Oxidative Stress; Presenilin-1; Signal Transduction; Sulfinic Acids | 2018 |
Allicin can reduce neuronal death and ameliorate the spatial memory impairment in Alzheimer's disease models.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Antioxidants; Cell Death; Disease Models, Animal; Disulfides; Dose-Response Relationship, Drug; Gene Expression Regulation; Hippocampus; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred Strains; Neurons; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Sulfinic Acids; Time Factors | 2010 |